Liquid biopsy in cancer treatment
LIQOMICS
26:27
How liquid biopsy can support cancer treatment decisions and follow up care.
Dr. med. Dr. rer. nat. Sven Borchmann will explain the value that ctDNA MRD testing (liquid biopsy) can offer for treatment decisions and follow up care. Afterwards, you will have the opportunity to ask your questions directly and discuss them with Dr. Borchmann.
Speaker
Sven Borchmann
Founder & CEO @ LIQOMICS
ctDNA-based MRD diagnostics for lymphoma & solid tumors | MD, PhD | Principal Investigator @ University of Cologne
Liquid biopsy in cancer treatment
26:27